FRX.TO · Fennec Pharmaceuticals Inc.
Canada · RS rating 63 · As of 2026-10-14
| Price | 14.47 CAD |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 20 / 44 / 65 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 34 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +18.3% |
| Distance from 52-week high | +17.9% |
| Market cap (USD) | $366.3M |